ADC Therapeutics (ADCT) Goodwill & Intangibles (2019 - 2023)

ADC Therapeutics (ADCT) has reported Goodwill & Intangibles for 5 consecutive years, with $12.4 million the latest figure, recorded in Q3 2023.

• Quarterly Goodwill & Intangibles fell 15.34% year-over-year to $12.4 million in Q3 2023, while the trailing twelve-month figure through Sep 2023 was $12.4 million (down 15.34% YoY) and the FY2022 annual result came in at $14.4 million, down 3.26% from the prior year.
• Goodwill & Intangibles slipped to $12.4 million in Q3 2023 per ADCT's latest filing, from $13.5 million in the prior quarter.
• Over the last five years, Goodwill & Intangibles for ADCT reached as high as $14.8 million in Q4 2021 and fell as low as $8.8 million in Q2 2020.
• A 5-year average of $12.4 million and a median of $13.3 million in 2021 frame the typical range for Goodwill & Intangibles.
• Annual changes were most pronounced in 2022 — Goodwill & Intangibles soared 36.5% — and 2023, when it declined 15.34%.
• Year by year, Goodwill & Intangibles stood at $9.4 million in 2019, then increased by 20.75% to $11.3 million in 2020, then soared by 31.22% to $14.8 million in 2021, then declined by 3.26% to $14.4 million in 2022, then fell by 13.94% to $12.4 million in 2023.
• According to Business Quant data, Goodwill & Intangibles over the past three periods registered $12.4 million, $13.5 million, and $13.6 million for Q3 2023, Q2 2023, and Q1 2023 respectively.